Current views on paediatric phaeochromocytoma and paraganglioma with a focus on newest guidelines

Area of Science:

• Pediatric Endocrinology
• Oncology
• Neuroendocrinology

Background:

• Phaeochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors originating from chromaffin cells.
• While most common in adults, PPGL also occur in children, with an incidence of 0.5 per million annually.
• Advances in adult PPGL care offer insights but pediatric cases present unique challenges.

Purpose of the Study:

• To provide an overview of pediatric phaeochromocytoma and paraganglioma diagnosis and management.
• To highlight recent international guidance specific to childhood PPGL.
• To emphasize the distinct nature of pediatric PPGL compared to adult cases.

Main Methods:

• Review of recent international clinical guidelines for PPGL.
• Synthesis of current knowledge on pediatric PPGL diagnosis and management.
• Focus on challenges and opportunities in pediatric PPGL care.

Main Results:

• Pediatric PPGL require tailored diagnostic and management strategies.
• International guidelines provide a framework for optimizing care in children.
• Recognizing pediatric PPGL as a distinct entity is crucial for effective treatment.

Conclusions:

• Improved clinical care for pediatric PPGL necessitates a distinct approach.
• Recent international guidance aids in addressing the specific needs of children with PPGL.
• Further research and tailored strategies are essential for advancing pediatric PPGL management.